[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,369,830
  • Shares Outstanding, K 130,212
  • Annual Sales, $ 727,330 K
  • Annual Income, $ -108,030 K
  • EBIT $ -106 M
  • EBITDA $ -36 M
  • 60-Month Beta 1.81
  • Price/Sales 1.82
  • Price/Cash Flow 30.41
  • Price/Book 1.60

Options Overview Details

View History
  • Implied Volatility 63.10% (-5.94%)
  • Historical Volatility 47.79%
  • IV Percentile 25%
  • IV Rank 7.90%
  • IV High 315.47% on 03/13/26
  • IV Low 41.44% on 08/15/25
  • Expected Move (DTE 18) 0.34 (3.23%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 439
  • Volume Avg (30-Day) 110
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 7,294
  • Open Int (30-Day) 9,109
  • Expected Range 10.18 to 10.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.06
  • Number of Estimates 3
  • High Estimate $-0.04
  • Low Estimate $-0.07
  • Prior Year $-0.06
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.18 +28.69%
on 05/13/26
10.65 -1.22%
on 05/29/26
+1.56 (+17.41%)
since 04/29/26
3-Month
7.07 +48.90%
on 03/30/26
10.65 -1.22%
on 05/29/26
+0.69 (+7.02%)
since 02/27/26
52-Week
4.72 +122.88%
on 08/01/25
13.74 -23.44%
on 01/12/26
+3.10 (+41.78%)
since 05/28/25

Most Recent Stories

More News
NeoGenomics to Present New Research at ASCO Annual Meeting 2026

Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies

NEO : 10.52 (+3.24%)
NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences:...

NEO : 10.52 (+3.24%)
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

NEO : 10.52 (+3.24%)
CRL : 180.71 (-0.35%)
3 Russell 2000 Stocks We’re Skeptical Of

3 Russell 2000 Stocks We’re Skeptical Of

MCY : 98.03 (+1.55%)
NEO : 10.52 (+3.24%)
AEO : 15.80 (-11.83%)
3 Reasons NEO is Risky and 1 Stock to Buy Instead

3 Reasons NEO is Risky and 1 Stock to Buy Instead

NEO : 10.52 (+3.24%)
5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call

NEO : 10.52 (+3.24%)
NEO Q1 Deep Dive: High-Value Test Expansion and Commercial Execution Drive Oncology Growth

NEO Q1 Deep Dive: High-Value Test Expansion and Commercial Execution Drive Oncology Growth

NEO : 10.52 (+3.24%)
NeoGenomics: Q1 Earnings Snapshot

NeoGenomics: Q1 Earnings Snapshot

NEO : 10.52 (+3.24%)
NeoGenomics’s (NASDAQ:NEO) Q1 CY2026: Beats On Revenue

NeoGenomics’s (NASDAQ:NEO) Q1 CY2026: Beats On Revenue

NEO : 10.52 (+3.24%)
NeoGenomics Reports First Quarter 2026 Results

First quarter total revenue increased 11% YoY to $187 million; Clinical revenue grew 14%, including NGS growth of 26%; Company announces...

NEO : 10.52 (+3.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 11.27
2nd Resistance Point 10.96
1st Resistance Point 10.74
Last Price 10.52
1st Support Level 10.21
2nd Support Level 9.90
3rd Support Level 9.68

See More

52-Week High 13.74
Last Price 10.52
Fibonacci 61.8% 10.29
Fibonacci 50% 9.23
Fibonacci 38.2% 8.17
52-Week Low 4.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.